This inventor holds 4 USPTO granted patents. Top assignees: Research, Incorporated, The Trustees of Boston College, The United States of America as Represented by the Department of Health. Active years: 1983-1998.
Company Filing History:
2 out of 444 
2 out of 116 
2 out of 1,217 
Years Active: 1983-1998
Title: T Ross Kelly: Innovator in Dimeric Arylisoquinoline Alkaloids
Introduction
T Ross Kelly is a notable inventor based in Watertown, MA (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of dimeric arylisoquinoline alkaloids. With a total of 4 patents to his name, his work has implications for medicinal chemistry and antiviral research.
Latest Patents
Kelly's latest patents focus on the preparation of dimeric arylisoquinoline alkaloids. His inventions provide methods for coupling isoquinoline building blocks with biaryl building blocks to create both homodimers and heterodimers. These compounds include the antiviral michellamines, which have potential medical applications. His patents emphasize the development of new, medically useful homodimeric and heterodimeric arylisoquinoline compounds and their derivatives.
Career Highlights
Throughout his career, T Ross Kelly has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the Trustees of Boston College. His research has contributed to advancements in the field of medicinal chemistry, particularly in the synthesis of complex alkaloid compounds.
Collaborations
Kelly has collaborated with notable colleagues such as Gerhard Bringmann and Michael R Boyd. These partnerships have further enriched his research and contributed to the development of innovative solutions in his field.
Conclusion
T Ross Kelly's work in the synthesis of dimeric arylisoquinoline alkaloids showcases his innovative spirit and dedication to advancing medicinal chemistry. His contributions continue to influence the field and hold promise for future medical applications.